NextGen Immuno Therapeutics Overview

  • Year Founded
  • 2025

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Latest Deal Amount
  • $1.13K

  • Investors
  • 1

NextGen Immuno Therapeutics General Information

Description

Developer of artificial intelligence-powered immune diagnostics designed for early detection and personalized treatment of immune-related diseases. The company offers a software-as-a-service platform integrating multimodal biological and clinical data by delivering biomarker discovery, patient stratification, and drug repurposing capabilities, enabling hospitals, researchers, and pharmaceutical businesses to improve outcomes, reduce complications, and achieve cost-effective precision medicine.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • Nippongasse 8
  • Vienna, 1220
  • Austria
+43 0650
Primary Industry
Other Healthcare Technology Systems
Other Industries
Outcome Management (Healthcare)
Discovery Tools (Healthcare)
Corporate Office
  • Nippongasse 8
  • Vienna, 1220
  • Austria
+43 0650

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NextGen Immuno Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 03-Jun-2025 $1.13K Completed Startup
To view NextGen Immuno Therapeutics’s complete valuation and funding history, request access »

NextGen Immuno Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NextGen Immuno Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
INiTS Universitäres Gründerservice Accelerator/Incubator
To view NextGen Immuno Therapeutics’s complete investors history, request access »

NextGen Immuno Therapeutics FAQs

  • When was NextGen Immuno Therapeutics founded?

    NextGen Immuno Therapeutics was founded in 2025.

  • Where is NextGen Immuno Therapeutics headquartered?

    NextGen Immuno Therapeutics is headquartered in Vienna, Austria.

  • What is the size of NextGen Immuno Therapeutics?

    NextGen Immuno Therapeutics has 5 total employees.

  • What industry is NextGen Immuno Therapeutics in?

    NextGen Immuno Therapeutics’s primary industry is Other Healthcare Technology Systems.

  • Is NextGen Immuno Therapeutics a private or public company?

    NextGen Immuno Therapeutics is a Private company.

  • What is NextGen Immuno Therapeutics’s current revenue?

    The current revenue for NextGen Immuno Therapeutics is .

  • How much funding has NextGen Immuno Therapeutics raised over time?

    NextGen Immuno Therapeutics has raised $1.13K.

  • Who are NextGen Immuno Therapeutics’s investors?

    INiTS Universitäres Gründerservice has invested in NextGen Immuno Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process